Navigation Links
UTMB scientists awarded NIH grant for lab-grown lung tissue project
Date:7/27/2012

University of Texas Medical Branch at Galveston researchers have been awarded a two-year, $1.25 million National Institutes of Health grant to develop a method of custom-growing human lung tissue to make a three-dimensional model for biomedical studies.

The lab-grown piece of lung, about the size of a dime, will form the core of a system intended to provide a powerful new option for testing new vaccines and drugs and studying disease processes in the lung.

"I'm so excited that the NIH is giving us this opportunity," said UTMB professor Joan Nichols, principal investigator on the project. "We've been working on tissue engineering for a long time, and developing this kind of model has always been one of our goals. These systems could really change the paradigm of what we do."

The NIH is also funding 16 other projects aimed at developing similar models using engineered human tissues, including those for the heart, liver, kidney, intestine and skin. Ultimately, the agency hopes to connect different tissue models together, in order to create a system that could simulate the combined responses of multiple organs.

Although animal models for disease and pharmaceutical testing have a long record of success, experimental models based on engineered human tissues would offer significant advantages to researchers, Nichols said.

"First, it's a human system, and while you can simulate human responses with animal models, it's never perfect," she said. "Second, it's easily managed, and it scales up easily, because having no animal care makes everything cheaper and easier. And if the thing you're testing is toxic, it's just cells you're not killing an animal."

According to Nichols, tissue-engineered models will also give researchers the ability to more easily conduct repeated observations in live tissue and apply advanced imaging techniques such as two-photon microscopy. They should also allow researchers to study diseases for which animal models are either nonexistent or prohibitively expensive, such as hepatitis C and Ebola.

To make engineered lung tissue for the project, Nichols needs to accomplish two main tasks. First, she has to generate a "scaffold," an extracellular protein network that will give structure to her creation. Then she has to add the right cells in the right quantities to grow tissue that will act as if though it's part of a real lung.

Nichols plans to either use an artificial scaffold or harvest a natural one from a pig lung, using a process that she and co-investigator Dr. Joaquin Cortiella developed to grow mouse lungs from stem cells. Choosing what kinds of cells to grow on the scaffold, she said, will be a matter of determining the best mix to accomplish two specific objectives: generating fibrosis, an all-too-common response to drug toxicity; and testing her system's responses to different strains of influenza.

"Like any organ, the lung has a lot of different cell types in it," Nichols said. "These tissues can be as complex as we want, but it's best to just start very simple and then build off of that we can evaluate the responses of just pneumocytes, or endothelial cells and pneumocytes together, or endothelial cells and pneumocytes and immune cells, like macrophages and neutrophils. It's important to know what each individual piece does."

Nichols is confident that she'll be able to meet the goals the NIH has set for the two-year award, opening up the possibility that she'll be selected to participate in the three-year-long second phase of the project. "After this we will probably join with whoever got kidney, whoever got liver, whoever got skin and so on, as well as whoever's making the system that this will all go in," she said. "Then we'll have something really significant, with all these units linked together interacting with each other, very much like your body would normally."


'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: